Investigation of the Relationship Between MD, MLR and NLR With APRs in Sepsis in the ICU
Key facts
- Who runs it
- Oguz Gundogdu
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 120 people enrolled
- Started
- 1 Oct 2022
- Ended
- 30 Jan 2024
- Type of study
- Observational, 3 groups
- Treatments tested
- Monocyte Distribution
- Record updated
- 17 April 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (11)Hide the full registry criteria
Who can take part
- Patients monitored in the intensive care unit for at least 24 hours
- Age over 18 years
- Diagnosis of sepsis or septic shock
Who cannot take part
- Patients who have undergone organ or bone marrow transplantation
- Patients receiving immunosuppressive therapy for any reason
- Patients with hematological diseases
- Patients with chronic renal failure
- Patients with liver failure not related to sepsis
- Patients with intracranial pathologies (e.g., mass, hemorrhage) that may lead to morbidity due to volume loading
- Patients diagnosed with AIDS
- Patients admitted due to intoxication
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of this study is to investigate, in patients admitted to the intensive care unit either for reasons other than sepsis who subsequently develop sepsis or with a primary diagnosis of sepsis, whether monocyte distribution, monocyte-to-lymphocyte ratio, and neutrophil-to-lymphocyte ratio can be used in addition to conventional biomarkers, and to examine their relationships with these biomarkers.
The 3 groups in the trial
- Group-I: Control
Control group - patients over 18 years of age, classified as ASA I-II, with no infection, who applied to the anesthesia outpatient clinic and did not meet any exclusion criteria.
Treatment: Monocyte Distribution
- Group-II
Group II: patients who were admitted to the intensive care unit for reasons other than sepsis and subsequently developed sepsis
Treatment: Monocyte Distribution
- Group-III
Group III: patients admitted to the intensive care unit with a primary diagnosis of sepsis.
Treatment: Monocyte Distribution
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Investigation of the Relationship Between Monocyte Distribution, Monocyte-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio With Acute Phase Reactants in Sepsis in the Intensive Care Unit
- Record updated
- 17 April 2026